Save over 33% on Tukysa from Europe
Non-english packaging - English label and English insert included. Plan in advance - allow us 7 days to ship your medicine
Marketing Authorisation Holder and Manufacturer
Seagen B.V.
Evert van de Beekstraat 1-104
1118CL Schiphol
The Netherlands
Information about Tukysa (Tucatinib)
Tukysa (Tucatinib) is an oral medication designed to treat advanced HER2-positive breast cancer. It works by selectively inhibiting HER2, a protein that promotes the growth of cancer cells. HER2-positive cancers tend to grow more aggressively, and tucatinib specifically targets and inhibits the action of this protein.
Product Highlights
- This includes cases that are unresectable (cannot be surgically removed) and have progressed despite other treatments.
- It is commonly used in combination with trastuzumab and capecitabine.
Key Ingredient
Key Benefits
- Tukysa has been shown to reduce tumor size and slow the progression of HER2-positive breast cancer.
- When used in combination with other therapies, it can extend survival and provide symptom relief for patients with advanced disease.
- The drug is taken by mouth, which offers convenience for patients compared to intravenous chemotherapy options.
Direction of Use
- Tukysa is typically taken as a 300 mg tablet once a day, either with or without food.
- It is often combined with other drugs, such as trastuzumab and capecitabine, based on the treatment plan prescribed by a healthcare provider.
- Patients should follow their doctor’s instructions regarding dosage and timing for optimal results.
Safety Concerns
- One of the most common side effects, and it can be severe in some patients. It’s important to monitor and manage this side effect.
- Tukysa can cause liver problems, so liver function tests are often performed before and during treatment.
- Although not as common, HER2 inhibitors can sometimes cause heart-related issues, so careful monitoring may be required.
- Tukysa may interact with other medications, including certain antibiotics and antifungals, so it’s important to inform the doctor of all other drugs being taken.
Avoid Tukysa (Tucatinib) If
- Since Tukysa can affect liver function, it should be avoided in patients with severe liver impairment.
- Allergic reactions can be serious, so avoid the drug if you have any known allergies to it.
- Tukysa may harm an unborn baby or pass into breast milk, so it is advised not to use it during pregnancy or breastfeeding without a doctor’s recommendation.
